Fortrea Executive and Leadership Team

Anshul Thakral, the Chief Executive Officer at Fortrea, directs the overarching strategic vision for the global clinical research organization. Thakral architects long-term growth initiatives while overseeing the integration of research and development services across North America, Europe, Asia Pacific, Africa, and South America. By aligning corporate objectives with the evolving needs of the pharmaceutical and biotechnology sectors, the Chief Executive Officer ensures the delivery of high-impact clinical solutions. Anshul Thakral maintains constant engagement with the Board to optimize operational efficiency and market positioning. This leadership role involves driving innovation in trial management to accelerate the path from medical concept to proven therapy. Through rigorous oversight of organizational performance, the Chief Executive Officer secures the company's status as a leader in clinical development. Thakral fosters a culture of scientific excellence, ensuring that every strategic decision supports the mission of improving patient outcomes through advanced research methodologies.

Oren Cohen, the Chief Medical Officer and President, Clinical Pharmacology Services at Fortrea, leads the scientific strategy and clinical pharmacology operations. Cohen directs the design and execution of early-phase clinical trials, ensuring that every study adheres to the highest levels of scientific rigor. By overseeing the specialized teams responsible for pharmacology, the Chief Medical Officer and President, Clinical Pharmacology Services translates complex medical data into actionable insights for biotechnology partners. Oren Cohen drives the development of innovative trial methodologies that accelerate the transition of medical ideas into proven therapies. This role involves close collaboration with regulatory bodies and internal research teams to maintain compliance and safety standards across global operations. Through the application of deep clinical expertise, the Chief Medical Officer and President, Clinical Pharmacology Services ensures that the company remains at the forefront of medical research. Cohen provides the technical leadership necessary to solve complex development challenges, ultimately supporting the delivery of life-changing medical solutions.

Madeshwaran Rajendran, the Chief Information Officer, Information Technology Vendor Management-Office at Fortrea, manages the complex digital infrastructure supporting global clinical trials. Rajendran oversees the strategic procurement and governance of technology vendors to ensure seamless data integration across international research facilities. By architecting robust IT frameworks, the Chief Information Officer, Information Technology Vendor Management-Office enables secure, efficient communication between specialized teams and healthcare clients. Madeshwaran Rajendran drives the digital transformation of research processes, implementing scalable systems that handle the massive data requirements of modern clinical development. This role involves mitigating operational risks through strict vendor compliance and performance monitoring. By optimizing the technology stack, the Chief Information Officer, Information Technology Vendor Management-Office supports the company's ability to deliver rapid, reliable research insights. Rajendran ensures that all technological investments align with the broader goal of accelerating therapy development while maintaining the highest standards of data integrity and security.

David Cooper, the Chief Administrative Officer at Fortrea, executes the internal operational strategies that sustain the company's global research network. Cooper oversees human capital management, facilities administration, and corporate infrastructure to ensure organizational agility across all regions. By streamlining administrative workflows, the Chief Administrative Officer supports the specialized teams tasked with navigating complex clinical trial environments. David Cooper drives initiatives that enhance operational efficiency, allowing the organization to scale effectively in competitive markets. This leadership role involves coordinating with other C-suite members to align administrative support with the company's scientific objectives. Through the implementation of standardized internal processes, the Chief Administrative Officer maintains the stability required for high-stakes research and development services. Cooper ensures that the corporate environment fosters innovation and collaboration, directly impacting the ability of the company to meet the rigorous demands of the pharmaceutical and healthcare industries while maintaining a consistent, high-quality operational standard.